Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS

  • Read more about ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS
US Patent 6,541,483
Filed on 2001-01-15

Method of Detecting a Predisposition to Cancer by Detecting a Deletion Polymorphism in The Gene For Human Poly (ADP-ribose) Polymerase

  • Read more about Method of Detecting a Predisposition to Cancer by Detecting a Deletion Polymorphism in The Gene For Human Poly (ADP-ribose) Polymerase
US Patent 5,449,605
Filed on 1993-04-06

p53 VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells

  • Read more about p53 VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells
US Application 09/830,977
Filed on 2001-05-02

Variants of Humanized Anti-Carcinoma MAB CC49

  • Read more about Variants of Humanized Anti-Carcinoma MAB CC49
US Patent 6,818,749
Filed on 2001-04-30

HETEROLOGOUS BOOSTING IMMUNIZATIONS

  • Read more about HETEROLOGOUS BOOSTING IMMUNIZATIONS
US Application 09/838,987
Filed on 2001-04-20

A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses

  • Read more about A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses
Patent Cooperation Treaty
PCT/US2001/019201
Filed on 2001-06-15

Cosalane Compounds And Methods For Their Use6182017

  • Read more about Cosalane Compounds And Methods For Their Use6182017
US Patent 6,562,805
Filed on 2001-01-29

Methods For Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity

  • Read more about Methods For Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity
Patent Cooperation Treaty
PCT/US2001/016058
Filed on 2001-05-18

Agents that Bind To And Inhibit Human Cytochrome P450 2C19

  • Read more about Agents that Bind To And Inhibit Human Cytochrome P450 2C19
US Patent 6,908,738
Filed on 2001-09-10

FLAVONE 8-ACETIC ACID AND INTERLEUKIN-2 FOR CANCER THERAPY

  • Read more about FLAVONE 8-ACETIC ACID AND INTERLEUKIN-2 FOR CANCER THERAPY
US Patent 5,096,707
Filed on 1988-04-15

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1490
  • Page 1491
  • Page 1492
  • Page 1493
  • Page 1494
  • Page 1495
  • Page 1496
  • Page 1497
  • Page 1498
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health